- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Nov 5, 2025 | 61.16M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 61.12M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 61.09M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 60.46M sh |
| Shares Diluted restated | Q2 2026 · Sep 30, 2024 | 60.36M sh |
| Capex | Q2 2026 · Sep 30, 2025 | $109.71M |
| Capex | Q2 2026 · Sep 30, 2024 | $33.64M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | $1.02B |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | $416.07M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $635.98M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $837.3M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2024 | $569.18M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $1.22B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $1.21B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $9.13B |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $8.7B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $10.35B |
| Total Assets | Q2 2026 · Mar 31, 2025 | $9.91B |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | $0.63 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | $1.13 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | $1.89 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | $2.46 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | $0.65 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | $1.15 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | $1.93 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | $2.51 |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $45.56M |
| Sga Expense | Q2 2026 · Sep 30, 2025 | $87.53M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $40.86M |
| Sga Expense restated | Q2 2026 · Sep 30, 2024 | $81.27M |
| Net Income | Q2 2026 · Sep 30, 2025 | $38.72M |
| Net Income | Q2 2026 · Sep 30, 2025 | $69.12M |
| Net Income | Q2 2026 · Sep 30, 2024 | $114.66M |
| Net Income | Q2 2026 · Sep 30, 2024 | $149.06M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $15.14M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $29.04M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $5.24M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $9.52M |
| Revenue | Q2 2026 · Sep 30, 2025 | $526.11M |
| Revenue | Q2 2026 · Sep 30, 2025 | $1.06B |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $586.14M |
| Revenue restated | Q2 2026 · Sep 30, 2024 | $1.04B |